CLINICAL RESEARCH
Epidemiology, Clinical Features, and Follow-Up of Patients With Syncope and a Positive Adenosine Triphosphate Test Result
Alain Perennes, MD,
Marjaneh Fatemi, MD,
Marie L. Borel, MD,
Yves Lebras,
Corinne L'Her, MD and
Jean-Jacques Blanc, MD*
Department of Cardiology, Hôpital de la Cavale Blanche, Brest University Hospital, Brest, France
Manuscript received July 8, 2005;
accepted September 8, 2005.
* Reprint requests and correspondence: Dr. Jean-Jacques Blanc, Department of Cardiology, Brest University Hospital, Boulevard Tanguy Prigent, 29609 Brest Cedex, France
(Email: jean-jacques.blanc{at}univ-brest.fr).
OBJECTIVES: We sought to evaluate epidemiology, clinical features, and outcomes of patients with syncope and an abnormal response to adenosine triphosphate (ATP).
BACKGROUND: Syncope remains of unknown origin in almost 30% of the patients. Injection of ATP induces in some of these patients, but not in control patients, a ventricular pause 6 s.
METHODS: Patients with syncope of unknown origin had an intravenous injection of 20 mg of ATP. All patients had a tilt test.
RESULTS: Among 214 patients, 19 (8.9%) had a positive ATP test result. The proportion of positive test results was higher (p < 0.002) in women (14.3%) than in men (2.2%). Ten patients (4.7%) had positive ATP and tilt test results. These patients (exclusively women) were older (p < 0.05) at the time of their fist syncope than the 67 patients with a negative ATP test result but a positive tilt test result. There was a trend for these two test results to be correlated (p = 0.07). Side effects were of short duration and benign. The mean duration of pauses was longer in women (p = 0.009). During a mean period of 31 ± 14 months, recurrences of syncope were reported in 25% of patients.
CONCLUSIONS: The ATP test is a safe test with an "abnormal" result in <10% of patients with syncope of unknown origin. The profile of these patients is characteristic.
|
Abbreviations and Acronyms
| | ATP = adenosine triphosphate | | AV = atrioventricular | | EPS = electrophysiological study | | HUT = head up tilt test | | SUO = syncope of unknown origin |
|
This article has been cited by other articles:

|
 |

|
 |
 
D. Flammang, T. R. Church, L. De Roy, J.-J. Blanc, J. Leroy, G. H. Mairesse, A. Otmani, P. J. Graux, R. Frank, P. Purnode, et al.
Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5'-Triphosphate Testing
Circulation,
January 3, 2012;
125(1):
31 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, J.-C. Deharo, L. De Roy, C. Menozzi, D. Blommaert, L. Dabiri, J. Ruf, and R. Guieu
Syncope Due to Idiopathic Paroxysmal Atrioventricular Block: Long-Term Follow-Up of a Distinct Form of Atrioventricular Block
J. Am. Coll. Cardiol.,
July 5, 2011;
58(2):
167 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Saadjian, V. Gerolami, R. Giorgi, L. Mercier, J.-L. Berge-Lefranc, F. Paganelli, Z. Ibrahim, Y. By, J. L. Gueant, S. Levy, et al.
Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism
Eur. Heart J.,
June 2, 2009;
30(12):
1510 - 1515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, J.-J. Blanc, R. Sutton, and A. Moya
CHAPTER 26 Syncope
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Viskin, D. Justo, and A. Halkin
Should the 'adenosine-challenge test' be part of the routine work-up for syncope?
Europace,
August 1, 2007;
9(8):
557 - 558.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D. G. Benditt, N. Grovale, T. De Santo, et al.
Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope
Eur. Heart J.,
September 2, 2006;
27(18):
2232 - 2239.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|